Cambridge Investment Research Regulatory Compliance and Partnerships

Cambridge Investment Research has a strong focus on regulatory compliance, with a dedicated team in place to ensure that all operations meet the highest standards. They have a comprehensive compliance program that includes regular audits and risk assessments.

Their regulatory compliance efforts are guided by a strict code of ethics and a commitment to transparency. Cambridge Investment Research is registered with the Securities and Exchange Commission (SEC) and is a member of the Financial Industry Regulatory Authority (FINRA).

As a result of their strong compliance program, Cambridge Investment Research has built a reputation for trust and integrity within the industry. This reputation is reflected in their ability to attract and retain top talent, as well as their strong relationships with clients and partners.

Cambridge Investment Research is a financial services firm that has been around since 1994. It's a registered investment advisor with the Securities and Exchange Commission.

The company is based in DeWitt, Iowa, and has a reputation for providing investment advice to financial advisors and their clients.

Cambridge Investment Research has a strong focus on supporting financial advisors in their practices, with a range of tools and services designed to help them succeed.

At Cambridge Investment Research, our mission is to provide exceptional service and support to our advisors and their clients. We do this by leveraging our resources, expertise, and technology to help them achieve their goals.

We believe that everyone deserves access to quality financial guidance and planning. Our team is dedicated to helping advisors build strong relationships with their clients and providing them with the tools and support they need to succeed.

With over $140 billion in assets under administration, we have the scale and resources to make a meaningful impact in the lives of our clients. Our advisors have access to a wide range of investment products and services, as well as expert guidance and support.

We're proud to be a part of the Cambridge family of companies, which includes a network of over 5,000 advisors across the US. Our advisors are committed to delivering exceptional service and results to their clients, and we're honored to be a part of their journey.

Our team at Cambridge Investment Research is dedicated to providing top-notch service and expertise to our clients. We have a deep understanding of the financial industry, with over 25 years of experience in financial services.

We're a team of experienced professionals, led by our CEO, Mary Kay Clark, who has been with the company since its inception. Our team members are passionate about helping individuals and families achieve their financial goals.

We're committed to staying up-to-date on the latest financial trends and technologies, ensuring that our clients receive the most effective and innovative solutions. Our team is comprised of experienced financial advisors, investment specialists, and administrative staff.

We're proud to have a team that is not only knowledgeable but also compassionate and empathetic, understanding that each client's situation is unique.

BridgePort Financial Solutions, a registered investment advisor launched by Cambridge Investment Research, has made significant strides in expanding its reach. It purchased two practices with a combined $400 million in assets under advisement.

In the first deal, BridgePort acquired 100% of PearTree Advisory Group, a Roseville, Calif.-based practice with about $275 million in AUA. PearTree was founded in 2006 by Brian Peardon and specializes in the ERISA retirement plan space.

BridgePort also took full ownership of Premier Wealth Advisors, an Indianapolis-based firm with about $140 million in assets. Robin Hall launched the firm in 2006, focusing on estate planning, business succession, investment advisory, and retirement income strategies for affluent multi-generational families.

Eddie Rollins, managing director of BridgePort, stated that these recent deals further BridgePort's purpose and commitment to provide advisors with tailored solutions for business continuity, succession planning, and long-term growth that ultimately benefit the clients.

BridgePort has made four 100% purchases since its launch, all of which were previously Cambridge advisors, and one minority acquisition of an outside firm. Advisors who sell 100% of their equity become employees of BridgePort and adopt the RIA's branding.

BridgePort initially targeted smaller, fee-only RIAs with between $50 million and $250 million in assets but is now seeing more opportunities to acquire in the $500 million to $1 billion space.

Cambridge Investment Research has been involved in a regulatory settlement with Finra, the Financial Industry Regulatory Authority.

Finra ordered the company to repay $8.2m in combined restitution to mutual fund customers.

The regulatory body alleged that Cambridge and other firms did not issue mutual fund sales charge waivers and fee rebates to eligible customers over a period of years.

Cambridge accepted Finra's findings without admitting or denying them.

Finra ordered Edward Jones, Osaic Wealth, and Cambridge Investment Research to pay over $8.2m in combined restitution to their mutual fund customers.

These three firms were found to have not issued mutual fund sales charge waivers and fee rebates to eligible customers over a period of years.

The regulatory body, Finra, alleged that the firms failed to provide the necessary rebates and waivers, leading to the order for repayment.

Edward Jones cooperated fully with Finra and has made enhancements to their policies, procedures, and practices to prevent similar issues in the future.

The firms accepted Finra's findings without admitting or denying them, and Edward Jones spokesperson stated that they are pleased to have resolved this matter.

Regulatory Compliance is a critical aspect of regulatory actions. Companies must ensure they comply with all relevant regulations to avoid fines and reputational damage.

The FDA has specific guidelines for medical device manufacturers, requiring them to follow Good Manufacturing Practice (GMP) regulations. This includes proper documentation and training of employees.

In 2019, the FDA issued a warning letter to a medical device manufacturer for failure to follow GMP regulations. The company was forced to recall its products and implement corrective actions.

The EU's Medical Device Regulation (MDR) requires manufacturers to conduct post-market surveillance and report adverse events. This helps to identify and address any potential safety issues.

The MDR also requires manufacturers to obtain CE marking for their devices, which indicates compliance with EU regulations. This marking is a critical step in bringing medical devices to market in the EU.

In the US, the FDA requires medical device manufacturers to register their facilities and list their devices with the agency. This helps to ensure transparency and accountability in the medical device industry.

The FDA also has specific guidelines for the labeling and advertising of medical devices. Manufacturers must ensure that their marketing materials are accurate and do not mislead consumers.

We're fortunate to have partnerships and alliances that support our independent financial professional business.

One of our valued partners is Cambridge Investment Research, Inc. They serve as our broker-dealer, providing essential services.

We utilize Cambridge Investment Research, Inc. to process investment transactions, which helps us streamline our work.

This partnership also offers marketing assistance, practice management, and education, which benefits our clients and our business.

As a result, we're able to focus on what matters most – helping our clients achieve their financial goals.

We've found that working with a reputable partner like Cambridge Investment Research, Inc. allows us to provide better service and guidance to our clients.